Full-Time
Customer Experience Representative
Remote, Canada, PT/MT
Posted on 8/30/2024
Biorender
201-500 employees
Online platform for creating scientific illustrations
No salary listed
Entry, Junior
Remote in Canada
Open to candidates in Canada living in Pacific and Mountain timezones.
Get referrals →
You have ways to get a Biorender referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 6 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
- 1+ years of experience in customer service (ideally in a SaaS or technology company)
- Bachelor's degree in the life sciences
- Strong interpersonal skills
- Experience using Zendesk, Intercom, or other customer support platform
- Interest / knowledge in the life sciences
- Self-starter with ability to thrive in a fast-paced environment
- Strong attention to detail
- Legally authorized to work in Canada, located in MST and PST time zone, and able to work some weekends
- Monitor and manage customer chat requests, providing real-time customer support and resolving any technical issues
- Liaise with the sales and product team to provide users the best possible experience
- Relay feedback from users to the product team, ensuring we address any technical glitches or bugs
- Understand user satisfaction and track NPS scores
- Monitor our company phone line and support email, responding to queries when they happen
BioRender provides an online platform for creating and sharing scientific illustrations tailored for the life sciences sector. Users can access thousands of pre-drawn icons and templates across more than 30 fields, allowing scientists, researchers, and educators to produce professional and visually appealing figures efficiently. The platform's user-friendly interface enables clients, including academic researchers, pharmaceutical companies, and educational institutions, to create illustrations for research papers, presentations, and educational materials with minimal effort. BioRender operates on a subscription-based model, offering various plans to suit different needs, including enterprise solutions for larger organizations. The company's goal is to simplify the process of creating high-quality scientific figures, making it an essential resource for those involved in scientific research and communication.
Company Size
201-500
Company Stage
Series A
Total Funding
$17.2M
Headquarters
Toronto, Canada
Founded
2017
Simplify's Take
What believers are saying
- Increased demand for visualization tools due to complex disease research like cancer and COVID-19.
- Growing interest in graphical abstracts boosts user engagement and platform adoption.
- Remote work trends increase the need for digital collaboration tools like BioRender.
What critics are saying
- Emerging AI-driven design tools could challenge BioRender's market position.
- Open-source illustration tools may reduce BioRender's subscription base.
- Demand for customizable figures may lead to client dissatisfaction with BioRender.
What makes Biorender unique
- BioRender offers a vast library of pre-drawn icons and templates for scientists.
- The platform is user-friendly, reducing time to create professional scientific figures.
- BioRender serves diverse clients, including academia, biotech, and pharmaceuticals.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 5%2 year growth
↑ 7%Wine and the pope; wine and heart health; wine and GenZ. It’s [mostly] all about wine this monthPope Francis praised Italian wine producers last year at an industry event VinitalyWhile the death of Pope Francis has touched people across the globe, perhaps Italian wine producers are feeling the loss a little more keenly. Last year the pope addressed a group of more than 100 Italian wine producers who were granted special audience with the pontiff during an industry promotional event. Though Argentine, the pope was of Italian descent, with his father originating from Asti, the heart of Piemonte’s wine country. The pope told the producers yours is “certainly a significant presence” in terms of production and employment, but also recognized their diligence in wisely using “wine, the land, farming skills and entrepreneurial activity, [which] are gifts from God.” Bringing it a more secular level, he praised the producers for “the fundamental lines along which you have chosen to move – care for the environment, work and healthy consumer habits – indicate an attitude centered on respect, at various levels.”The special Vatican wine EL PAISIn related news, wine-searcher.com makes note that the election of a new pope may affect the fortunes of Spanish winery Heras Cordón in Rioja, which has been the exclusive supplier of wine for the Vatican since 2001 under the selection of John Paul II and continued by the subsequent popes. The only winery in Spain to hold the official Vatican supplier certificate produces 2000 bottles of the Vatican wine per year
Findings could point to new ways to treat RAS-driven cancers BETHESDA, Md., Nov. 12, 2024 /PRNewswire/ -- Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface. Mutant RAS, they found, helps to kick off a series of events involving the transport of specific nuclear proteins that lead to uncontrolled tumor growth, according to a study published Nov. 11, 2024, in Nature Cancer
Peer-reviewed study offers first description of ongoing NETosis induction in Long COVID; provides insights into pathogenesis and can serve as a surrogate marker for persistent pathology Research emphasizes need to explore neutrophil-targeted therapies in acute and chronic COVID-19SALT LAKE CITY, April 13, 2023 /PRNewswire/ -- Peel Therapeutics, an evolutionary-inspired, clinical-stage biotech company, announced research conducted by the company has been published in The Journal of Thrombosis and Haemostasis. The study, NETosis Induction Reflects COVID-19 Severity and Long COVID: Insights from a Two-Center Patient Cohort Study in Israel, evaluated the ability of blood from Israeli patients with Long COVID to induce neutrophil extracellular traps (NETs) as a marker of ongoing inflammation. NETs are sticky webs of DNA released by activated immunes cells that contribute to immunothrombosis (mini-clots) and fibrosis. Peel scientists also correlated NETosis potential with acute disease severity in COVID-19. The study concluded that NET inhibitors may be a possible treatment approach for COVID-19 and recommended additional research to confirm findings. Peel Therapeutics is developing first-in-class Neutrophil Targeting Peptides (NTPs) – originating from natural NET inhibitors in newborns – to block inflammation leading to immunothrombosis and fibrosis
Cancer cells surround themselves with a cloud of adenosine, thereby inhibiting the immune system (left). Ceritinib stops the formation of adenosine. ATP accumulates and activates immune cells (right). Figure: Laura Schäkel/University of Bonn – created with BioRender.com. German scientists say a drug already approved for other purposes can negate how tumor cells protect themselves from the immune system
Today BioRender, creator of the first web-based graphical tool for scientists to create publication and presentation-ready figures, announced its inaugural Graphical Abstract Contest, to give scientists a way to promote their research and win prize rewards.